Note: Ingredients listed on restricted chemical lists
EC/CAS
9003-39-8
Name of the chemical
polyvinylpyrrolidone
Concentration
2.47
EC/CAS
14807-96-6
Name of the chemical
Talc
Concentration
0.82
EC/CAS
13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
0.35
General Information
Revision date
2024-01-29
Product name
ERIVEDGE(R) Capsules (150 mg)
Product Synonyms
syno- ERIVEDGE Capsules 150 mg nym(s) of the substance
1.2.1 Relevant identified uses
Formulated pharmaceutical active substance
supplier name
Genentech, Inc
Emergency telephone
001-(650) 225-1000, (800)-424-9300
Icons in SDS
Company Information
company name
Genentech, Inc
e-mail address of the competent person responsible for the Safety Data Sheet
info.sds@roche.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H350, H360FD, H373
Hazard statements
Code
Statements
H350
May cause cancer
Section 2
SECTION 2: Hazards identification
OSHA Hazards GHS classification in accordance with the
2.1 Classification of the substance or mixture
in accordance with the
Signal word
Danger
Hazard statements
H350 May cause cancer. H360FD May damage fertility. May damage the unborn child. H373 May cause damage to organs through prolonged or re- peated exposure.
Prevention
P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. P260 Do not breathe dust. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection.
Response
P308 + P313 IF exposed or concerned: Get medical advice/ attention.
Storage
P405 Store locked up.
Disposal
P501 Dispose of contents/ container to an approved waste dis- posal plant.
Other hazards
None known
